SSRIs (Selective Serotonin Reuptake Inhibitors)

What it is

SSRIs (selective serotonin reuptake inhibitors) are antidepressant medicines that raise serotonin signaling; citalopram doses above 40 mg/day are unsafe. They are among the most commonly prescribed first-line medicines for major depressive disorder and are also used for several anxiety-related conditions because they are generally safer in overdose and better tolerated than many older antidepressants. Common SSRIs include fluoxetine, sertraline, paroxetine, citalopram, escitalopram, and fluvoxamine. In practice, the choice depends on the condition being treated, side-effect profile, age, other medicines, pregnancy considerations, and past response.

A quick comparison:

SSRI	Common uses	Notable point
Sertraline	Depression, panic disorder, OCD, PTSD, social anxiety	Often chosen when drug interactions need to be minimized
Fluoxetine	Depression, OCD, bulimia nervosa, panic disorder	Long half-life, which can reduce withdrawal symptoms
Escitalopram	Depression, generalized anxiety disorder	Often well tolerated
Citalopram	Depression	Higher doses can prolong QT interval; dose limits matter
Paroxetine	Depression, anxiety disorders, PMDD	More anticholinergic effects and more discontinuation symptoms
Fluvoxamine	OCD, sometimes anxiety disorders	More drug interaction potential

In India, SSRIs are widely used by psychiatrists and other clinicians for depression and anxiety disorders. They are prescription medicines and should not be started, stopped, or switched without medical supervision.

How it works

SSRIs block the serotonin transporter (SERT) on presynaptic nerve cells. This reduces reuptake of serotonin after it is released into the synapse, leaving more serotonin available to signal between neurons. That is the immediate pharmacologic effect, but symptom improvement usually takes longer because downstream changes in receptor sensitivity and brain network function develop over days to weeks.

This delay is important clinically. Many people do not feel better in the first few days, and some may notice side effects before benefits. For depression, a meaningful response often takes 2 to 6 weeks, and sometimes longer. Anxiety symptoms can also improve gradually and may briefly feel worse early in treatment, especially if the starting dose is too high.

SSRIs differ in half-life, liver metabolism, and how strongly they affect drug-metabolizing enzymes. For example, fluoxetine has a long half-life, while paroxetine is more likely to cause discontinuation symptoms if stopped abruptly. These differences matter when changing medicines, planning pregnancy, or managing interactions.

Evidence and uses

SSRIs have good evidence for major depressive disorder and several anxiety and obsessive-compulsive spectrum disorders. They are commonly used for:

1. Major depressive disorder
2. Generalized anxiety disorder
3. Panic disorder
4. Obsessive-compulsive disorder
5. Post-traumatic stress disorder
6. Social anxiety disorder
7. Premenstrual dysphoric disorder
8. Bulimia nervosa, for fluoxetine in particular

They are considered first-line in many guidelines because they balance efficacy, safety, and ease of use. That said, they are not universally effective. Some people improve substantially with the first SSRI, while others need a different SSRI, another drug class, psychotherapy, or combination treatment.

SSRIs are also used off-label for some conditions, but evidence is stronger for some uses than others. For example, there is established use in premature ejaculation and some chronic pain-related symptom clusters, but benefits can be modest and must be weighed against adverse effects.

For children, adolescents, and young adults, SSRIs can be effective for selected conditions, but they require closer monitoring because antidepressants carry a boxed warning about increased risk of suicidal thoughts and behaviors in younger people. This does not mean SSRIs should never be used in youth. It means follow-up is important, especially in the first weeks and after dose changes.

Safety and interactions

Common side effects include nausea, loose stools, headache, sweating, sleep disturbance, restlessness, tremor, and sexual dysfunction. Some people gain weight over time, though this varies by drug and duration. Early side effects often ease after the first 1 to 2 weeks, but sexual side effects may persist.

Important safety issues include:

Issue	Why it matters
Suicidal thoughts warning	Highest concern in children, adolescents, and young adults, especially early in treatment
Serotonin syndrome	Risk rises when combined with other serotonergic drugs such as MAOIs, linezolid, tramadol, triptans, or some supplements
Bleeding risk	SSRIs can increase bleeding risk, especially with NSAIDs, aspirin, clopidogrel, or anticoagulants
Hyponatremia	More likely in older adults and can cause confusion, falls, or seizures
QT prolongation	Especially relevant with citalopram at higher doses
Mania activation	Can occur in people with bipolar disorder if an SSRI is used without appropriate mood-stabilizing treatment
Discontinuation symptoms	More common with short half-life SSRIs such as paroxetine if stopped suddenly

Drug interactions matter. Some SSRIs inhibit liver enzymes and can change levels of other medicines. Combining SSRIs with MAO inhibitors is dangerous and requires a washout period. Herbal products and supplements can also interact. St. John's wort is a well-known example that can increase serotonin-related risk and alter drug metabolism. Before starting an SSRI, tell your clinician or pharmacist about all prescription drugs, over-the-counter medicines, and supplements.

Pregnancy and breastfeeding decisions are individualized. Untreated depression also carries risks, so the question is not simply whether a drug has any risk, but whether treatment benefits outweigh risks in a specific situation. This should be discussed with an obstetrician and psychiatrist or prescribing clinician.

When to see a clinician

See a clinician if low mood, loss of interest, anxiety, panic, obsessions, or compulsions are affecting sleep, work, study, or relationships for more than 2 weeks, or sooner if symptoms are severe. Seek urgent help if there are suicidal thoughts, self-harm, extreme agitation, confusion, high fever, muscle rigidity, or a sudden marked change in behavior after starting or changing an antidepressant.

If you are already taking an SSRI, contact your clinician if side effects are severe, sexual dysfunction is distressing, sleep becomes much worse, or you think the medicine is not helping after several weeks. Do not stop suddenly unless a clinician tells you to. Abrupt discontinuation can cause dizziness, anxiety, electric-shock sensations, nausea, and flu-like symptoms.

Limitations and open questions

SSRIs help many people, but they are not a complete explanation or cure for depression and anxiety. The older idea that these disorders are simply caused by a "low serotonin" state is too simplistic. Modern research suggests more complex brain, psychological, inflammatory, and social mechanisms.

Evidence is strong for several approved uses, but there are still open questions about who responds best, how to predict side effects, and how long treatment should continue after remission. Comparative differences between individual SSRIs are often clinically relevant but not always large in trials. Long-term effects such as emotional blunting, persistent sexual symptoms in a small subset of patients, and withdrawal phenomena remain active areas of study.

For patients, the practical point is that SSRI treatment works best when it is monitored, reviewed, and combined with a broader care plan when needed, including psychotherapy, sleep support, substance-use assessment, and management of medical comorbidities.